Global Hemostats Market – Industry Trends from 2017 to 2024


Posted May 2, 2017 by ravikantdubey

The global hemostats market has accounted to USD 2.7 billion in 2016, and is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 6.5% in the forecast period 2017 to 2024.

 
Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

The global hemostats market is segmented based on product type, indication, end-user and geography.

On the basis of product the market is segmented into into 5 product type’s thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments.

The Global Hemostats market is also segmented based on indications type into wound closure and surgery.

Based on end-users the market is segmented into hospitals, clinics, ambulatory centers, community healthcare and others.

Request for sample pages: http://databridgemarketresearch.com/reports/global-hemostats-market-trends-forecast-2024/

Based on geography the global hemostats devices market covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. North America dominates the market in terms of consumption of hemostats followed by Europe and APAC. . In terms of revenue North America holds 57.7% of the market in 2015, followed by Europe with 20.1% and APAC with 14.2%. APAC is expected to be the fastest growing market in the forecasted years owing to increasing number of surgeries in this region among other growth opportunities.

“Read more about Global Hemostats Market”

Some of the other major players operating in this market are Pfizer, C.R. Bard, Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (A Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, Medtrade Products Ltd., Integra Lifesciences Corporation, Medline Industries, Inc., Hemotec Medical GmbH, Stryker, Hemostasis, LLC., CSL Behring, Mallinckrodt plc. and Equimedical, B.V. among other companies.

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Data Bridge Market Research Private Limited
Website Data Bridge Market Research Private Limited
Phone +1-888-387-2818
Business Address Amanora Chambers, Magarpatta Road, Hadapsar
Pune – 411028 Maharashtra, India
Country India
Categories Health , Manufacturing , Medical
Tags Wound Closure , tissue sealants , Tissue Adhesives , Thrombin Based Hemostat , Passive Hemostasis , Oxidized Regenerated Cellulose Based Hemostat , Mechanical Hemostasis , Acitve Hemostasis
Last Updated May 2, 2017